Nykode
Oslo
About Nykode
Nykode Therapeutics is a clinical-stage biopharmaceutical platform that develops technology for novel vaccines and immunotherapy against HPV-induced malignancies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $35.5M
- Funding stage: IPO
- Last round: Series Unknown (Dec 2016)
- Ticker: ose:NYKD
- Website: vaccibody.com
- Phone: 47 22 95 81 90
Industries & Categories
Biotechnology, Clinical Trials, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/nykode-71421 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.